391 related articles for article (PubMed ID: 17711889)
1. Neuropsychiatric involvement in pediatric systemic lupus erythematosus.
Benseler SM; Silverman ED
Lupus; 2007; 16(8):564-71. PubMed ID: 17711889
[TBL] [Abstract][Full Text] [Related]
2. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
Mikdashi J; Handwerger B
Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study.
Harboe E; Tjensvoll AB; Maroni S; Gøransson LG; Greve OJ; Beyer MK; Herigstad A; Kvaløy JT; Omdal R
Ann Rheum Dis; 2009 Oct; 68(10):1541-6. PubMed ID: 18930990
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
[TBL] [Abstract][Full Text] [Related]
7. [Neuropsychiatric involvement in systemic lupus erythematosus. Part 1: clinical presentation and pathogenesis].
Weiner SM; Peter HH
Med Klin (Munich); 2002 Dec; 97(12):730-7. PubMed ID: 12491066
[TBL] [Abstract][Full Text] [Related]
8. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
[TBL] [Abstract][Full Text] [Related]
9. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
Hanly JG; Robichaud J; Fisk JD
J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
[TBL] [Abstract][Full Text] [Related]
10. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.
Mikdashi J; Krumholz A; Handwerger B
Neurology; 2005 Jun; 64(12):2102-7. PubMed ID: 15985581
[TBL] [Abstract][Full Text] [Related]
11. [Neuropsychiatric manifestations in systemic lupus erythematosus].
Alexa ID; Stoica MS; Paraschiv O; Rusu RI
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):322-5. PubMed ID: 17802940
[TBL] [Abstract][Full Text] [Related]
12. [Neuropsychiatric symptoms and findings in systemic lupus erythematosus ].
Lund C; Gjerstad L
Tidsskr Nor Laegeforen; 1997 May; 117(14):2043-5. PubMed ID: 9235685
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric manifestations in a consecutive cohort of systemic lupus erythematosus; a single center study.
Abdul-Sattar AB; Goda T; Negm MG
Int J Rheum Dis; 2013 Dec; 16(6):715-23. PubMed ID: 24382281
[TBL] [Abstract][Full Text] [Related]
14. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
[TBL] [Abstract][Full Text] [Related]
15. Echolalia as a novel manifestation of neuropsychiatric systemic lupus erythematosus.
Zapor M; Murphy FT; Enzenauer R
South Med J; 2001 Jan; 94(1):70-2. PubMed ID: 11213948
[TBL] [Abstract][Full Text] [Related]
16. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients.
Govoni M; Bombardieri S; Bortoluzzi A; Caniatti L; Casu C; Conti F; De Vita S; Doria A; Farina I; Ferraccioli G; Gremese E; Mansutti E; Mosca M; Padovan M; Piga M; Tincani A; Tola MR; Tomietto P; Taglietti M; Trotta F; Valesini G; Zen M; Mathieu A;
Rheumatology (Oxford); 2012 Jan; 51(1):157-68. PubMed ID: 22075066
[TBL] [Abstract][Full Text] [Related]
17. Longterm outcomes and damage accrual in patients with childhood systemic lupus erythematosus with psychosis and severe cognitive dysfunction.
Lim LS; Lefebvre A; Benseler S; Silverman ED
J Rheumatol; 2013 Apr; 40(4):513-9. PubMed ID: 23457384
[TBL] [Abstract][Full Text] [Related]
18. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus.
Olfat MO; Al-Mayouf SM; Muzaffer MA
Clin Rheumatol; 2004 Oct; 23(5):395-9. PubMed ID: 15278752
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
[TBL] [Abstract][Full Text] [Related]
20. Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus.
Descloux E; Durieu I; Cochat P; Vital-Durand D; Ninet J; Fabien N; Cimaz R
Rheumatology (Oxford); 2009 Jul; 48(7):779-84. PubMed ID: 19416945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
